Cognition Therapeutics Announces New Conversations Episode on Therapeutic Strategies to Protect the Retina in Dry AMD

<p>PURCHASE, N.Y., Sept. 07, 2023 (GLOBE NEWSWIRE) &#8212; Cognition Therapeutics, Inc., (Nasdaq: CGTX), (the “Company” or “Cognition”) has released its sixth “Conversations” video podcast, which features an interactive discussion with retinal specialists about dry age-related macular degeneration (dry AMD) and the current treatment landscape. Dry AMD is caused by a degeneration of the macula and [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/cognition-therapeutics-announces-new-conversations-episode-on-therapeutic-strategies-to-protect-the-retina-in-dry-amd/">Cognition Therapeutics Announces New Conversations Episode on Therapeutic Strategies to Protect the Retina in Dry AMD</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>